All Stories

  1. Permeability of the HIV-1 capsid to metabolites modulates viral DNA synthesis
  2. Truncated CPSF6 Forms Higher-Order Complexes That Bind and Disrupt HIV-1 Capsid
  3. Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon
  4. A spatio-temporal assessment of simian/human immunodeficiency virus (SHIV) evolution reveals a highly dynamic process within the host
  5. Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+T CellsIn Vitro
  6. Rilpivirine and Doravirine have complementary efficacies against NNRTI-Resistant HIV-1 mutants
  7. Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants
  8. No compartmentalization of RT-SHIV in blood vs. tissues
  9. Difficulty in detection of resistant virus in RT-SHIV infected macaques treated with RPV LA
  10. Expression of reporter genes in SIV can allow visualization of infected cells in live animals
  11. Systematic Analysis of Intracellular Trafficking Motifs Located within the Cytoplasmic Domain of Simian Immunodeficiency Virus Glycoprotein gp41
  12. Correlative Imaging and Cryo-FIB Processing for Direct Visualization of HIV-1 Infection
  13. Multiple genes associated with inflammation are upregulated in tissues during RT-SHIV infection
  14. HIV-1 uncoating: connection to nuclear entry and regulation by host proteins
  15. RT-SHIV can be suppressed by antiretroviral therapy and can be used to study viral latency
  16. Correction
  17. Novel imaging assay reveals biphasic capsid uncoating of HIV-1
  18. Ultrasensitive Allele-Specific PCR Reveals Rare Preexisting Drug-Resistant Variants
  19. Use of Animal Models for Anti-HIV Drug Development
  20. Identification of HIV Inhibitors Guided by Free Energy Perturbation Calculations
  21. N74D HIV-1 capsid mutant has increased dependence on cyclophilin A, cannot replicate in macrophages
  22. Intact HIV-1 capsid cores were directly visualized in the cytoplasm of human cells
  23. ART did not decrease genetic diversity of RT-SHIV
  24. CPSF6 binds HIV-1 capsid and cytoplasmic expression restricts infection
  25. RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy
  26. The Nucleoside Analogue D-carba T Blocks HIV-1 Reverse Transcription
  27. HIV-1 containing SIV Vif replicated in pigtailed macaques
  28. HIV-1 with I132M in RT decreases nucleotide selectivity
  29. The use of animal models in HIV/AIDS therapeutics and pre-exposure prophylaxis
  30. A candidate microbicide sensitized macaques to SIV infection upon second exposure
  31. Study of RT inhibitor resistance in a macaque model of HIV/AIDS
  32. A novel HIV-1 RT inhibitor causes delayed DNA chain termination
  33. The use of animal models in HIV/AIDS research
  34. NNRTI resistance can be caused by mutations in the RT p51 subunit, far from the active site
  35. More RT in HIV-1 requires more NNRTI to inhibit infection
  36. SIV containing HIV-1 RT can be inhibited by anti-HIV-1 RT inhibitors
  37. Mucosal vaccination enhanced anti-SIV/HIV immune responses and reduced viral infection
  38. SIV/HIV replicates at the initial site of infection (mucosa) before spreading to other tissues